Trademark Alertz ®
Search
Trademark
Owner
Trademark: 2164117
Word
Device Descrption:
DISC,SEGMENTED FORMS ANTIBODY
ID
2164117
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
01 December 2020
Registration Date
01 December 2020
Renewal Date
01 December 2030
Owner(s)
CytoDyn Inc.
Service
Goods and Services:
Class 5
:
Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
;
therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor.
Class 42
:
Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
;
medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
;
medical research services in the field of antibodies for use in targeting the CCR5 cell receptor.
Class 44
:
Providing health and medical information, and providing health and medical information in the nature of providing information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, via a website
;
providing health and medical information, via a website
;
providing information in the field of antibodies for use in targeting the C-C chemokine receptor type 5 cell receptor, via a website
;
medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19.